Track BB Biotech AG — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BB Biotech AG BBZA.DE · Stock Open BB Biotech AG in new tab

58.50 EUR
EPS
-8.60
Yield
4.00%
Safety Score
92
P/B
0.99
ROE
54.76
Beta
0.66
Loading chart...
Key Metrics
Earnings dateOct. 23, 2026
EPS-8.60
Book Value59.71
Price to Book0.99
% Insiders0.078%
Growth
Revenue Growth1162.58%
Estimates
Forward P/E27.21
Forward EPS2.17
Dividend
Dividend Yield4.00%
Annual dividends2.25 EUR
Ex-Div. DateMarch 23, 2026
Payout9.20%

DCF Valuation

Tweak assumptions to recompute fair value for BB Biotech AG (BBZA.DE)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

BB Biotech AG Logo BB Biotech AG Analysis (BBZA.DE)

Is BB Biotech AG a good investment? BB Biotech AG (BBZA.DE) is currently trading at 58.50 EUR.

Earnings Schedule: BB Biotech AG is expected to release its next earnings report on Oct. 23, 2026. The market consensus estimate for Forward EPS is 2.17.

For income investors, BB Biotech AG pays a dividend yield of 4.00%. With a payout ratio of 9%, the dividend appears sustainable.

Investor FAQ

Does BB Biotech AG pay a dividend?

Yes, it pays an annual dividend of 2.25 EUR (4.00% yield).

What asset class is BB Biotech AG?

BB Biotech AG is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Oct. 23, 2026. The company currently has a trailing EPS of -8.60.

Company Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Exchange Ticker
SIX BION.SW
BBZA.DE
Trades
Dividend Yield
4.00%
Annual Dividends
2.25EUR
Next Ex. Div Date
March 23, 2026
Payout Ratio
9.20%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
2.19 EUR
March 29, 2027 (estimated) 2.1879
2026
4.84 EUR
March 25, 2026 2.4311
March 23, 2026 2.4075
2025
1.60 EUR
March 21, 2025 1.6038
2024
4.20 EUR
March 27, 2024 2.0593
March 25, 2024 2.1400
2023
5.90 EUR
March 29, 2023 2.8500
March 27, 2023 3.0495
2022
7.97 EUR
March 23, 2022 3.8500
March 21, 2022 4.1195
2021
7.45 EUR
March 24, 2021 3.6000
March 22, 2021 3.8520
2020
3.40 EUR
March 25, 2020 3.4000
2019
3.05 EUR
March 27, 2019 3.0500
2018
3.30 EUR
March 19, 2018 3.3000
2017
2.75 EUR
March 22, 2017 2.7500
Upcoming Dividends
Name Payment Date Status Amount
BB Biotech AG Mar 23, 2026 2.4075 EUR
BB Biotech AG Mar 25, 2026 2.43113 EUR
Stock Splits
Split Date Split Ratio to 1
March 29, 2016 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion